Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kapsula - tetraciklin

Evropska unija - slovenščina - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alkaloid - int d.o.o. - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin

Evropska unija - slovenščina - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - doksorubicinijev klorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - risedronska kislina - šumeča zrnca + filmsko obložena tableta - risedronska kislina 32,5 mg / 1 tableta - risedronska kislina, kalcij in holekalciferol, zaporedni

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - risedronska kislina - šumeča zrnca + filmsko obložena tableta - risedronska kislina 32,5 mg / 1 tableta - risedronska kislina, kalcij in holekalciferol, zaporedni

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - holekalciferol (vitamin d3); kalcij - žvečljiva tableta - holekalciferol (vitamin d3) 880 mg / 1 tableta  kalcij1000 mg / 1 tableta; kalcij 1000 mg / 1 tableta - kalcij, kombinacije z vitaminom d in/ali drugimi učinkovinami

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

holekalciferol (vitamin d3); kalcij - žvečljiva tableta - holekalciferol (vitamin d3) 880 i.e. / 1 tableta  kalcij1000 i.e. / 1 tableta; kalcij 1000 i.e. / 1 tableta - kalcij, kombinacije z vitaminom d in/ali drugimi učinkovinami

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin